SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ:AFFX) today announces the GeneTitan™ System, the only complete platform to automate customer workflow from target preparation through array processing and data analysis, which maximizes data reproducibility, user productivity and throughput scalability. The first application, whole-genome expression profiling, benefits from the new, flexible 24- and 96-array plate format with whole-genome content on a single array and the new HT 3’ IVT Express Assay, which uses a streamlined protocol and less starting material.
